National Advertising Division Finds Certain DUPIXENT Claims Supported; Recommends Sanofi Modify or Discontinue Other Claims
Following a challenge brought by Galderma Laboratories, L.P., BBB National Programs’ National Advertising Division found certain challenged claims…